KEZAR LIFE SCIENCES
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders. In parallel with this work, Christopher and Kezar co-founder Jack Taunton, Ph.D. collaborated on several research projects involving protein secretion. This collaboration inspired a belief in the strong synergies between protein degradation and protein secretion, two fertile areas for drug discovery with platform potential.
KEZAR LIFE SCIENCES
Industry:
Health Care Health Diagnostics Life Science Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.kezarlifesciences.com
Total Employee:
11+
Status:
Active
Contact:
(650)822-5600
Email Addresses:
[email protected]
Total Funding:
123 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator Comcast KnowBe4 DocuSign
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Kezar Life Sciences
Solasta Ventures
Solasta Ventures investment in Post-IPO Equity - Kezar Life Sciences
Omega Funds
Omega Funds investment in Series B - Kezar Life Sciences
Pappas Ventures
Pappas Ventures investment in Series B - Kezar Life Sciences
Bay City Capital
Bay City Capital investment in Series B - Kezar Life Sciences
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Kezar Life Sciences
Cowen Group
Cowen Group investment in Series B - Kezar Life Sciences
Morningside Group
Morningside Group investment in Series B - Kezar Life Sciences
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Kezar Life Sciences
Chiesi Ventures
Chiesi Ventures investment in Series B - Kezar Life Sciences
Key Employee Changes
Official Site Inspections
http://www.kezarlifesciences.com Semrush global rank: 8.23 M Semrush visits lastest month: 349
Unable to get host informations!!!
More informations about "Kezar Life Sciences"
Our Company - Kezar Life Sciences Inc.
Apr 21, 2022 At Kezar Life Sciences, we are developing first-in-class, small molecule therapies designed to inhibit multiple disease-driving cellular pathways by targeting key intracellular proteins.See details»
Executive Team - Kezar Life Sciences Inc.
Jun 2, 2022 Before joining Kezar Life Sciences, Joe held significant roles at Assembly Biosciences, AbbVie, Amgen, and Genentech. He earned his Bachelorโs in Interpersonal & โฆSee details»
Kezar Life Sciences - Crunchbase Company Profile
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders. In parallel with this work, Christopher and Kezar co-founder Jack Taunton, Ph.D. collaborated โฆSee details»
Kezar Life Sciences - LinkedIn
Kezar Life Sciences Biotechnology Research South San Francisco, California 5,074 followers Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disordersSee details»
Kezar Life Sciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
Kezar Life Sciences - PitchBook
Aug 31, 2020 Kezar Life Sciences General Information Description. Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small โฆSee details»
Kezar Life Sciences - VentureRadar
Website: http://www.kezarlifesciences.com/ Develops breakthrough treatments for immune-mediated and oncologic disorders by pioneering first-in-class, small molecule ...See details»
Kezar Life Sciences - Overview, News & Similar companies
Apr 8, 2024 Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar โฆSee details»
Press Release Details - Kezar Life Sciences, Inc.
Jun 30, 2024 For more information, visit www.kezarlifesciences.com, and follow us on LinkedIn, Facebook, Twitter and Instagram. Cautionary Note on Forward-looking Statements. This press โฆSee details»
Contact Us - Kezar Life Sciences Inc.
Corporate Headquarters. 4000 Shoreline Court Suite 300 South San Francisco, CA 94080See details»
Kezar Life Sciences Announces Strategic Restructuring to Prioritize ...
Oct 3, 2023 For more information, visit www.kezarlifesciences.com and follow us on LinkedIn, Facebook, Twitter and Instagram. Cautionary Note on Forward-looking Statements.See details»
Kezar Life Sciences Receives FDA Clearance of IND for โฆ
Oct 3, 2022 For more information, visit www.kezarlifesciences.com. Cautionary Note on Forward-looking Statements This press release contains forward-looking statements within the โฆSee details»
Press Release Details - Kezar Life Sciences, Inc.
Mar 4, 2019 Kezar is also poised to expand its development programs throughout 2019 with plans to initiate Phase 2 trials of KZR-616, in up to four additional autoimmune indications, and โฆSee details»
Kezar Life Sciences Reports First Quarter 2024 Financial Results โฆ
May 9, 2024 SOUTH SAN FRANCISCO, Calif., May 09, 2024--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule โฆSee details»
John Fowler - Kezar Life Sciences Inc.
John Fowler is our Co-Founder and a member of the board of directors. He served as Chief Executive Officer of Kezar from June 2015 to November 2023. Prior to Kezar, between 2009 โฆSee details»
Press Release Details - Kezar Life Sciences, Inc.
Jun 27, 2022 11 of 17 patients (64.7%) achieved an overall renal response of 50% or greater reduction in urine protein to creatinine ratio (UPCR) at 6 months 6 of 17 patients (35.2%) โฆSee details»
Kezar Life Sciences, Inc. (Kezar Life Sciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
Zetomipzomib (KZR-616) is a selective inhibitor of the immunoproteasome currently undergoing clinical investigation in autoimmune disorders. Here, we characterized KZR-616 in vitro and in โฆSee details»
Clinical Trials - Kezar Life Sciences Inc.
Kezar Life Sciences is committed to developing safe and effective therapies for serious diseases that impact patients and their families. To achieve this, we conduct clinical trials to assess the โฆSee details»
Kezar Life Sciences Announces Interim Results from the MISSION โฆ
Nov 15, 2021 For more information, visit www.kezarlifesciences.com. Cautionary Note on Forward-looking Statements This press release contains forward-looking statements within the โฆSee details»